10,000+ stock pitches from top investors available on joinyellowbrick.com
RA CAPITAL MANAGEMENT, L.P. 13F Holdings
Holdings from the most recent 13F from RA CAPITAL MANAGEMENT, L.P.
Filed: 2025-02-14 (Q4 2024) | Holdings: 90 | Value: $7.5B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
|---|---|---|---|---|---|---|---|
| Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
| ASND - ASCENDIS PHARMA A/S - ADR | Add 4% ($55.4M) | 18.53% | $1.4B | +22.04% | +8.29% | ||
| PCVX - VAXCYTE INC | 9.47% | $711.3M | -58.34% | -63.01% | |||
| JANX - JANUX THERAPEUTICS INC | Add 13% ($64.2M) | 7.39% | $555.0M | -32.37% | -36.44% | ||
| RYTM - RHYTHM PHARMACEUTICALS INC | 4.53% | $340.6M | +16.95% | +6.34% | |||
| LEGN - LEGEND BIOTECH CORP-ADR | 3.25% | $244.3M | -14.92% | -25.16% | |||
| EWTX - EDGEWISE THERAPEUTICS INC | 3.17% | $237.9M | -42.15% | -43.60% | |||
| NAMS - NEWAMSTERDAM PHARMA CO NV | Add 10% ($20.1M) | 3.03% | $227.3M | -2.16% | -6.22% | ||
| WVE - WAVE LIFE SCIENCES LTD | 3.00% | $225.2M | -38.13% | -42.25% | |||
| ACLX - ARCELLX INC | Add 51% ($71.8M) | 2.84% | $213.8M | +1.13% | -10.78% | ||
| RNA - AVIDITY BIOSCIENCES INC | 2.44% | $183.2M | +9.78% | -10.64% | |||
| SEPN - SEPTERNA INC | New Purchase | 2.13% | $160.2M | +152.28% | +142.69% | ||
| DYN - DYNE THERAPEUTICS INC | 2.00% | $150.3M | -0.71% | -16.68% | |||
| TYRA - TYRA BIOSCIENCES INC | Add 2% ($3.1M) | 1.97% | $147.9M | -24.10% | -26.42% | ||
| RXST - RXSIGHT INC | Reduce 4% $(6.0M) | 1.71% | $128.7M | -50.18% | -55.56% | ||
| BCAX - BICARA THERAPEUTICS INC | 1.61% | $121.2M | -18.78% | +6.55% | |||
| LENZ - LENZ THERAPEUTICS INC | 1.61% | $120.6M | +19.24% | +7.60% | |||
| SPRY - ARS PHARMACEUTICALS INC | 1.52% | $114.6M | +10.89% | +0.62% | |||
| ETNB - 89BIO INC | 1.48% | $110.9M | -5.77% | -27.72% | |||
| XBI - SPDR S&P BIOTECH ETF | New Purchase | 1.47% | $110.6M | -10.10% | -15.52% | ||
| GERN - GERON CORP | Reduce 7% $(8.1M) | 1.41% | $106.2M | -38.58% | -52.36% | ||
| ARTV - ARTIVA BIOTHERAPEUTICS INC | 1.32% | $99.3M | -55.45% | -51.59% | |||
| AXSM - AXSOME THERAPEUTICS INC | 1.13% | $84.6M | -11.23% | -13.99% | |||
| VRNA - VERONA PHARMA PLC - ADR | Reduce 65% $(150.6M) | 1.09% | $82.1M | +31.26% | +6.69% | ||
| DAWN - DAY ONE BIOPHARMACEUTICALS I | Reduce 27% $(26.8M) | 0.97% | $72.9M | -43.31% | -49.76% | ||
| APGE - APOGEE THERAPEUTICS INC | Reduce 20% $(17.8M) | 0.95% | $71.1M | +2.45% | +10.59% | ||
| MLYS - MINERALYS THERAPEUTICS INC | 0.79% | $59.7M | +53.29% | +50.74% | |||
| PRAX - PRAXIS PRECISION MEDICINES I | 0.78% | $58.6M | -53.45% | -59.02% | |||
| RXRX - RECURSION PHARMACEUTICALS-A | Reduce 50% $(51.8M) | 0.69% | $52.2M | -60.40% | -63.17% | ||
| CLYM - CLIMB BIO INC | 0.69% | $52.1M | -17.88% | -20.53% | |||
| TRML - TOURMALINE BIO INC | 0.69% | $51.5M | +35.32% | +11.17% | |||
| ACRV - ACRIVON THERAPEUTICS INC | 0.67% | $50.2M | -77.40% | -80.11% | |||
| FULC - FULCRUM THERAPEUTICS INC | 0.64% | $48.1M | +92.68% | +78.86% | |||
| TXG - 10X GENOMICS INC-CLASS A | New Purchase | 0.63% | $47.1M | -27.58% | -26.87% | ||
| GHRS - GH RESEARCH PLC | 0.62% | $46.8M | -11.63% | -25.02% | |||
| ATXS - ASTRIA THERAPEUTICS INC | 0.61% | $45.6M | -26.38% | -43.72% | |||
| VOR - VOR BIOPHARMA INC | New Purchase | 0.59% | $44.0M | -83.91% | -87.71% | ||
| GPCR - STRUCTURE THERAPEUTICS INC | Reduce 20% $(10.3M) | 0.55% | $41.2M | -10.50% | +1.83% | ||
| DNTH - DIANTHUS THERAPEUTICS INC | Reduce 20% $(10.2M) | 0.54% | $40.7M | -24.60% | -23.87% | ||
| PEPG - PEPGEN INC | 0.54% | $40.5M | +5.97% | +6.72% | |||
| EVH - EVOLENT HEALTH INC - A | Reduce 58% $(55.5M) | 0.54% | $40.2M | -18.59% | -12.33% | ||
| KURA - KURA ONCOLOGY INC | New Purchase | 0.52% | $38.8M | -21.60% | -29.00% | ||
| IDYA - IDEAYA BIOSCIENCES INC | 0.46% | $34.6M | +0.48% | -17.57% | |||
| ZLAB - ZAI LAB LTD-ADR | New Purchase | 0.45% | $33.9M | +18.91% | -6.44% | ||
| CMRX - CHIMERIX INC | New Purchase | 0.41% | $30.6M | ||||
| CDTX - CIDARA THERAPEUTICS INC | New Purchase | 0.39% | $29.4M | +0.71% | -11.89% | ||
| MBX - MBX BIOSCIENCES INC | 0.37% | $27.9M | +12.63% | +1.14% | |||
| NKTX - NKARTA INC | 0.36% | $26.9M | -18.30% | -23.21% | |||
| ABOS - ACUMEN PHARMACEUTICALS INC | 0.34% | $25.7M | -26.21% | -30.34% | |||
| FDMT - 4D MOLECULAR THERAPEUTICS IN | Reduce 10% $(3.0M) | 0.34% | $25.4M | -19.88% | -34.43% | ||
| NRIX - NURIX THERAPEUTICS INC | New Purchase | 0.33% | $25.1M | -29.42% | -46.58% | ||
| BCYC - BICYCLE THERAPEUTICS PLC-ADR | Reduce 100% | 0.00% | $0.00 | ||||
| BIIB - BIOGEN INC | Reduce 100% | 0.00% | $0.00 | ||||
| BIOA - BIOAGE LABS INC | Reduce 100% | 0.00% | $0.00 | ||||
| CCCC - C4 THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| CGON - CG ONCOLOGY INC | Reduce 100% | 0.00% | $0.00 | ||||
| ELVN - ENLIVEN THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| ITOS - ITEOS THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| LRMR - LARIMAR THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| SLDB - SOLID BIOSCIENCES INC | Reduce 100% | 0.00% | $0.00 | ||||